Vera Therapeutics Inc. stock traded on the Nasdaq exchange on August 4, 2026, and received analyst ratings from Bank of America.
9 reports, 3 independent
Updated Sep 12
Gone quiet
- Reports
- 9
- Developments
- 2
- Repetition
- 78%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vera Therapeutics Inc. stock traded on the Nasdaq exchange on August 4, 2026, and received analyst ratings from Bank of America.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Vera Therapeutics received multiple rating upgrades from Bank of America, TD Cowen, and Jefferies.1 source
Vera Therapeutics stock traded on Nasdaq and received ratings from Bank of America.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Bank of America
American multinational banking and financial services corporation
Related events
- Incannex Healthcare Inc. stock was traded on the Nasdaq exchange on June 29, 2026.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- BioCryst Pharmaceuticals traded on the NASDAQ electronic stock exchange on September 12, 2026.
- BrightSpring Health Services stock is trading on the Nasdaq exchange.
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.